{"transactions":[{"id":709978,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-15T00:21:11.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":14150,"derivative":{"exercise_price":0.68,"exercise_date":"2027-07-09","expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001958857-26-000003","document":"form4-07152026_120706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000195885726000003/form4-07152026_120706.xml","form_type":"4"}},{"id":851708,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-10T23:22:52.000Z","date":"2026-03-08","kind":"grant","planned":false,"acquired":true,"shares":33435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof.  The stock options under this award will vest 100% on the first anniversary of the grant date."}],"balance_after":33435,"derivative":{"exercise_price":1.6,"exercise_date":"2027-03-08","expiration_date":"2036-03-08","underlying":"Common Stock","underlying_shares":33435},"source":{"system":"sec-edgar","filing":"0001958857-26-000002","document":"form4-03102026_110349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000195885726000002/form4-03102026_110349.xml","form_type":"4"}},{"id":968032,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-12-16T23:22:44.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":24629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":24629,"derivative":{"exercise_price":2.33,"exercise_date":"2026-12-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":24629},"source":{"system":"sec-edgar","filing":"0001958857-25-000007","document":"form4-12162025_111241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000195885725000007/form4-12162025_111241.xml","form_type":"4"}},{"id":968031,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T23:22:44.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":6157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis."}],"balance_after":6157,"source":{"system":"sec-edgar","filing":"0001958857-25-000007","document":"form4-12162025_111241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000195885725000007/form4-12162025_111241.xml","form_type":"4"}},{"id":1018772,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-10-16T00:04:01.000Z","date":"2025-10-12","kind":"grant","planned":false,"acquired":true,"shares":11530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the first anniversary of the grant date."}],"balance_after":11530,"derivative":{"exercise_price":3.01,"exercise_date":"2026-10-12","expiration_date":"2035-10-12","underlying":"Common Stock","underlying_shares":11530},"source":{"system":"sec-edgar","filing":"0001958857-25-000006","document":"form4-10162025_121057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000195885725000006/form4-10162025_121057.xml","form_type":"4"}},{"id":1104179,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2025-06-23T21:59:03.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":23000,"derivative":{"exercise_price":1.65,"exercise_date":"2026-06-19","expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001415889-25-017997","document":"form4-06232025_090659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588925017997/form4-06232025_090659.xml","form_type":"4"}},{"id":1808818,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2023-08-14T21:47:57.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":66468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":66468,"derivative":{"exercise_price":1.02,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":66468},"source":{"system":"sec-edgar","filing":"0001415889-23-012230","document":"form4-08142023_090847.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588923012230/form4-08142023_090847.xml","form_type":"4"}},{"id":2082217,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":30605,"kind":"person","name":"Clarke Trafford","position":1,"cik":"0001958857","reported_name":"Clarke Trafford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2022-12-19T23:59:20.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in 3 installments on the anniversary of the grant date: 33% on the first anniversary, 33% on the second anniversary and 34% on the third anniversary."}],"balance_after":100000,"derivative":{"exercise_price":0.71,"expiration_date":"2032-12-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-22-012768","document":"form4-12192022_111209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000141588922012768/form4-12192022_111209.xml","form_type":"4"}}]}